• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.

作者信息

van Dijk E, Bakkers E J, Go M J, Montnor L P, Roessel F E, van der Wateren A R, Wuite J

出版信息

Cutis. 1983 Sep;32(3):284-5, 287.

PMID:6354613
Abstract

Seventy-three patients with psoriasis were treated in an open multicenter study with betamethasone dipropionate 0.05 percent cream (twice daily application for four days) alternated with the cream base (twice daily application for three days). The therapeutic response at the end of the treatment period of three weeks was very satisfactory: 39 patients had marked improvement or recovery, 16 patients had moderate improvement, and 14 patients had slight improvement. These results did not differ from those of a study on continuous treatment with betamethasone dipropionate cream in the treatment of psoriasis. Side effects (folliculitis) were only noted in one patient.

摘要

相似文献

1
Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
Cutis. 1983 Sep;32(3):284-5, 287.
2
Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.外用0.005%卡泊三烯和0.064%二丙酸倍他米松在中重度斑块状银屑病患者逐步减量后维持依那西普的疗效:一项开放标签试验的结果
J Drugs Dermatol. 2011 Aug;10(8):878-82.
3
0.05 percent betamethasone dipropionate in optimized cream vehicle for psoriasis.用于银屑病的含0.05%二丙酸倍他米松的优化乳膏载体
Cutis. 1989 Feb;43(2):178-82.
4
A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
Clin Ther. 1989 Nov-Dec;11(6):768-74.
5
A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.倍他米松二丙酸酯乳膏每日两次与每日一次治疗激素反应性皮肤病疗效的双盲比较
Clin Exp Dermatol. 1989 Jan;14(1):32-4. doi: 10.1111/j.1365-2230.1989.tb00879.x.
6
A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.0.05%丙酸氯倍他索软膏与优化后的0.05%二丙酸倍他米松软膏治疗银屑病的比较。
Cutis. 1986 Mar;37(3):213-4, 216, 218-20.
7
Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.
Arch Dermatol. 1976 May;112(5):681-3.
8
Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.倍他米松二丙酸酯外用二醇制剂治疗重度银屑病的疗效
Clin Ther. 1980;3(3):156-67.
9
Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.
J Int Med Res. 1983;11 Suppl 1:31-3.
10
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
Clin Ther. 1983;5(3):290-8.

引用本文的文献

1
Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.各种丙酸氯倍他索剂型在治疗类固醇反应性皮肤病中的相对疗效及互换性
Curr Ther Res Clin Exp. 2005 May;66(3):154-71. doi: 10.1016/j.curtheres.2005.06.010.